Antimicrobial resistance companies develop diagnostics, therapeutics and technologies to address infections that no longer respond effectively to existing medicines. Their work supports faster pathogen identification, improved treatment decisions and the development of new approaches to infection control.
This category includes companies working on:
Browse 57 UK antimicrobial resistance companies below.
Small-molecule anti-biofilm add-on therapy for antibiotic-resistant urinary tract infections
BioTryp Therapeutics is a UK-based drug discovery company developing small-molecule therapies that inhibit bacterial biofilm formation. The company's lead programme is an oral…
Portable multiplex PCR molecular diagnostic platform for point-of-care use
QuantuMDx is a medical technology company developing a battery-operated, handheld molecular diagnostic system that delivers multiplex PCR results from a single-use reagent…
Global drug discovery and development partnership company
Evotec is a global drug discovery and development company with major UK operations at Milton Park, Abingdon, and Alderley Park, Cheshire. Its Abingdon campus houses over 800 staff…
Controlled-release orthobiologics for spinal fusion and bone repair
Locate Bio is a clinical-stage biotechnology company developing a portfolio of orthobiologic products for musculoskeletal surgery. Its proprietary Programmed Drug Release platform…
Microbiology CRO for antimicrobial product testing and regulatory support
BluTest Laboratories Limited is a UKAS-accredited contract research organisation providing microbiology testing and development services to manufacturers of antimicrobial…
Immunoaffinity test kits for food, feed, and clinical diagnostics
R-Biopharm Rhône is a Glasgow-based manufacturer and distributor of immunoaffinity columns and analytical test kits for food safety, feed analysis, and clinical diagnostics. The…
Integrated academic drug discovery facility for anti-infectives and innovative targets
The Drug Discovery Unit is an academic drug discovery facility at the University of Dundee, integrating medicinal chemistry, high-throughput screening, structural biology, cell…
Bacteriophage antimicrobials targeting livestock pathogens to replace antibiotics
Aparon is a biotechnology company developing bacteriophage-based technologies as novel antimicrobials for use in livestock production. Its research focuses on identifying and…
AI-powered rapid pathogen ID and antibiotic susceptibility from blood
Vivid Dx is a University of Oxford spin-out developing a culture-free diagnostics platform for rapid pathogen identification and antimicrobial susceptibility testing directly from…
Phase III-ready antimicrobial advancing post-surgical infection prevention
AMR Bio is a clinical-phase biotechnology company advancing XF-73, a Phase III-ready topical antimicrobial using an ultra-rapid antibacterial mechanism to prevent post-surgical…
Food and gut health bioscience research on Norwich Research Park
Quadram Institute Bioscience is a BBSRC-funded independent research organisation focused on the interactions between food, gut microbiota, and human health. Operating within the…
Novel antibiotic-sparing therapeutics for chronic wound care
ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds. The company's pipeline centres on a patented…